Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
Tyrosine kinases (TK) are enzymes capable of transferring phosphate groups to tyrosine residues in cytoplasmic proteins or the intracellular domains of transmembrane receptors. TK play critical roles in diverse biological functions including cellular processes such as adhesion, motility, proliferati...
Main Authors: | Gomez-Puerta, Jose A., Mócsai, Attila |
---|---|
Format: | Online |
Language: | English |
Published: |
Bentham Science Publishers
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796894/ |
Similar Items
-
Tyrosine kinases in rheumatoid arthritis
by: Okamoto, Hiroshi, et al.
Published: (2011) -
Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib
by: Ni, Han, et al.
Published: (2013) -
Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis
by: Coffey, Greg, et al.
Published: (2013) -
Transport Mechanisms and Their Pathology-Induced Regulation Govern Tyrosine Kinase Inhibitor Delivery in Rheumatoid Arthritis
by: Schmidt-Lauber, Christian, et al.
Published: (2012) -
Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis
by: Sara Remuzgo-Martínez, et al.
Published: (2017-09-01)